Results 211 to 220 of about 2,831 (235)
Some of the next articles are maybe not open access.
Seminars in Ophthalmology
Purpose To evaluate and contrast the effectiveness and safety of two conbercept treatment protocols—a three-dose treat-and-extend (3+T&E) regimen and a three-dose pro re nata (3+PRN) regimen—in Chinese patients diagnosed with neovascular age-related ...
Yaoyao Sun +46 more
semanticscholar +1 more source
Purpose To evaluate and contrast the effectiveness and safety of two conbercept treatment protocols—a three-dose treat-and-extend (3+T&E) regimen and a three-dose pro re nata (3+PRN) regimen—in Chinese patients diagnosed with neovascular age-related ...
Yaoyao Sun +46 more
semanticscholar +1 more source
One-Year Outcome of Conbercept Therapy for Diabetic Macular Edema
Current Eye Research, 2017To evaluate the therapeutic efficacy of conbercept for the treatment of diabetic macular edema (DME) with different baseline visual acuity.This is a retrospective, comparative study. A total of 107 eyes of 107 patients were included. According to the levels of baseline best corrected visual acuity (BCVA) and therapeutic regimen, the DME patients were ...
Fengjiao, Li +6 more
openaire +2 more sources
Retina
PURPOSE To introduce a vitrectomy technique for the submacular hemorrhage (SMH) combined with subretinal tenecteplase (TNK-tPA) injection, intravitreal conbercept administration, perfluoropropane (C3F8) gas tamponade, and to evaluate its efficacy and ...
Mingwei Cui, Xiaomei Zhen, Shancheng Si
semanticscholar +1 more source
PURPOSE To introduce a vitrectomy technique for the submacular hemorrhage (SMH) combined with subretinal tenecteplase (TNK-tPA) injection, intravitreal conbercept administration, perfluoropropane (C3F8) gas tamponade, and to evaluate its efficacy and ...
Mingwei Cui, Xiaomei Zhen, Shancheng Si
semanticscholar +1 more source
INTRAVITREAL CONBERCEPT (KH902) FOR SURGICAL TREATMENT OF SEVERE PROLIFERATIVE DIABETIC RETINOPATHY
Retina, 2016To evaluate the role, safety, and effectiveness of intravitreal conbercept (KH902) injections as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy.A randomized controlled trial was performed on 36 eyes of 36 patients affected by vitreous hemorrhage and tractional retinal detachment, which occurred as a consequence ...
Long, Su +8 more
openaire +2 more sources
European Journal of Ophthalmology
Purpose Choroidal neovascularization secondary to pathologic myopia (PM-CNV) is an important main factor leading to decreased vision in patients with pathologic myopia. Conbercept, an anti-VEGF drug, is currently the primary treatment for PM-CNV.
Yeqiang Shi +4 more
semanticscholar +1 more source
Purpose Choroidal neovascularization secondary to pathologic myopia (PM-CNV) is an important main factor leading to decreased vision in patients with pathologic myopia. Conbercept, an anti-VEGF drug, is currently the primary treatment for PM-CNV.
Yeqiang Shi +4 more
semanticscholar +1 more source
SHORT-TERM EFFICACY OF CONBERCEPT AND RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
Retina, 2019Purpose: To compare the 6-month efficacy of the intravitreal injection of conbercept or ranibizumab for patients with polypoidal choroidal vasculopathy (PCV). Methods: This is a retrospective case–control study involved 79 PCV eyes of 77 patients.
Zhen, Huang +6 more
openaire +2 more sources
Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration
Expert Review of Clinical Pharmacology, 2015Age-related macular degeneration (AMD) is a progressive, degenerative disease of the retina that occurs with increasing incidence with age and ranks third among the global causes of visual impairment. VEGF has been implicated in the development and progression of neovascular AMD.
Thanh T, Nguyen, Robyn, Guymer
openaire +2 more sources